INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,029,000 | -65.6% | 175,000 | -73.1% | 0.54% | -73.0% |
Q2 2016 | $2,989,000 | +13.7% | 650,000 | +1.9% | 2.00% | +21.8% |
Q1 2016 | $2,629,000 | -22.1% | 638,000 | +1.3% | 1.64% | +16.1% |
Q4 2015 | $3,377,000 | -4.3% | 630,000 | 0.0% | 1.41% | -18.7% |
Q3 2015 | $3,528,000 | – | 630,000 | – | 1.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,125,153 | $4,951,000 | 3.63% |
ACUTA CAPITAL PARTNERS, LLC | 2,962,568 | $13,035,000 | 2.32% |
DAFNA Capital Management LLC | 568,600 | $2,502,000 | 1.17% |
MEITAV INVESTMENT HOUSE LTD | 2,450,592 | $11,425,000 | 0.51% |
SECTORAL ASSET MANAGEMENT INC | 890,386 | $3,918,000 | 0.44% |
Avoro Capital Advisors LLC | 2,570,705 | $11,311,000 | 0.44% |
Cormorant Asset Management, LP | 773,816 | $3,405,000 | 0.25% |
CAXTON CORP | 64,817 | $285,000 | 0.10% |
Migdal Insurance & Financial Holdings Ltd. | 522,067 | $2,297,000 | 0.06% |
683 Capital Management, LLC | 150,000 | $660,000 | 0.04% |